ICU Acquired Antibiotic Resistant Organism (ARO) rate: Difference between revisions
Jump to navigation
Jump to search
Ttenbergen (talk | contribs) mNo edit summary |
|||
Line 15: | Line 15: | ||
==Sampling Plan / Procedure== | ==Sampling Plan / Procedure== | ||
100 % of all patients will be monitored for acquired resistant organisms to antibiotics. | |||
===Includion Criteria=== | ===Includion Criteria=== | ||
{{discuss | who=Julie | question= What are the details? }} | {{discuss | who=Julie | question= What are the details? }} |
Revision as of 14:15, 2019 August 13
Identification of new MRSA, VRE or ESBL colonization in ICU patient
Indicators | |
Indicator: | ICU Acquired Antibiotic Resistant Organism (ARO) rate |
Created/Raw: | Created |
Program: | Critical Care |
Start Date: | |
End Date: | |
Reports: | Critical Care Program Quality Indicator Report |
QI domain
- Safe
Significance
ARO can cause significant morbidity and mortality. The spread of these organisms can be decreased with good hand hygiene and antibiotic stewardship.
Sampling Plan / Procedure
100 % of all patients will be monitored for acquired resistant organisms to antibiotics.
Includion Criteria
Exclusion Criteria
Frequency
Definition and Derivation
Identification of new MRSA, VRE or ESBL colonization in ICU patient
Is it still defined just around those? Should it now be defined around Category:Antibiotic resistance? |
New ARO Colonization per 1000 ICU patient days
Is it really only colonization, or does/should this include infections? Category:Antibiotic resistance? |
Numerator
Denominator
Data Sources
SAS Program
Report Users
Related articles
Related articles: |